TRVI
Trevi Therapeutics Inc

1,823
Mkt Cap
$1.69B
Volume
1.94M
52W High
$14.39
52W Low
$3.47
PE Ratio
-34.39
TRVI Fundamentals
Price
$12.77
Prev Close
$13.17
Open
$13.12
50D MA
$11.38
Beta
0.77
Avg. Volume
1.84M
EPS (Annual)
-$0.4698
P/B
8.63
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Trevi Therapeutics (NASDAQ:TRVI) Trading 5.7% Higher - Time to Buy?
Trevi Therapeutics (NASDAQ:TRVI) Stock Price Up 5.7% - Should You Buy...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Trevi Therapeutics, Inc. $TRVI Shares Acquired by Vivo Capital LLC
Vivo Capital LLC grew its stake in shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI - Free Report) by 28.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·4d ago
News Placeholder
226,381 Shares in Trevi Therapeutics, Inc. $TRVI Bought by Prudential Financial Inc.
Prudential Financial Inc. bought a new stake in Trevi Therapeutics, Inc. (NASDAQ:TRVI - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities...
MarketBeat·6d ago
News Placeholder
Trevi Therapeutics, Inc. $TRVI Shares Purchased by Geode Capital Management LLC
Geode Capital Management LLC boosted its stake in shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI - Free Report) by 10.6% in the 2nd quarter, according to the company in its most recent disclosure...
MarketBeat·8d ago
News Placeholder
Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer
Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer PR Newswire NEW HAVEN...
PR Newswire·9d ago
News Placeholder
Trevi Therapeutics (NASDAQ:TRVI) Sets New 52-Week High - Still a Buy?
Trevi Therapeutics (NASDAQ:TRVI) Sets New 12-Month High - Here's What Happened...
MarketBeat·16d ago
News Placeholder
AXQ Capital LP Invests $227,000 in Trevi Therapeutics, Inc. $TRVI
AXQ Capital LP bought a new stake in Trevi Therapeutics, Inc. (NASDAQ:TRVI - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange...
MarketBeat·17d ago
News Placeholder
MAI Capital Management Sells 537,497 Shares of Trevi Therapeutics, Inc. $TRVI
MAI Capital Management trimmed its holdings in shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI - Free Report) by 38.8% in the 2nd quarter, according to the company in its most recent disclosure with...
MarketBeat·19d ago
News Placeholder
Leerink Partnrs Has Bullish Outlook for TRVI FY2025 Earnings
Trevi Therapeutics, Inc. (NASDAQ:TRVI - Free Report) - Leerink Partnrs increased their FY2025 earnings estimates for shares of Trevi Therapeutics in a note issued to investors on Tuesday, November...
MarketBeat·21d ago
News Placeholder
B. Riley Increases Earnings Estimates for Trevi Therapeutics
Trevi Therapeutics, Inc. (NASDAQ:TRVI - Free Report) - Stock analysts at B. Riley increased their FY2025 earnings estimates for Trevi Therapeutics in a research note issued to investors on Monday...
MarketBeat·22d ago

Latest TRVI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.